Clinical Trial Update: TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trials of TAB08 for psoriasis vulgaris have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• TAB08

Snippet

Sponsor: Theramab LLC | Conditions: Psoriasis Vulgaris | Phase 1, Phase 2 | Status: COMPLETED